Federated Hermes’s Cerevel Therapeutics Holdings, Inc. Warrant CEREW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-283,333
Closed -$4.04M 2374
2021
Q2
$4.04M Hold
283,333
0.01% 892
2021
Q1
$1.2M Hold
283,333
﹤0.01% 1304
2020
Q4
$1.6M Buy
+283,333
New +$1.14M ﹤0.01% 1147

Federated Hermes's CEREW Position: Q3 2021 in Review

Federated Hermes sold out of Cerevel Therapeutics Holdings, Inc. Warrant (CEREW) in Q3 2021, closing a stake of 283,333 shares — an estimated $4.04M sold.

Federated Hermes first reported a position in CEREW in Q4 2020 and held it in 3 quarters. The position peaked at $4.04M in Q2 2021. 0 funds tracked by Wall St. Rank hold CEREW as of Q3 2021.

  • Federated Hermes reported no remaining Cerevel Therapeutics Holdings, Inc. Warrant position as of Q3 2021 after selling out during the quarter.
  • Federated Hermes sold 283,333 Cerevel Therapeutics Holdings, Inc. Warrant shares in Q3 2021, an estimated $4.04M.
  • Federated Hermes first reported a position in Cerevel Therapeutics Holdings, Inc. Warrant in Q4 2020 and held it in 3 quarters.
  • Federated Hermes's Cerevel Therapeutics Holdings, Inc. Warrant position peaked at $4.04M in Q2 2021.
  • 0 funds tracked by Wall St. Rank held Cerevel Therapeutics Holdings, Inc. Warrant as of Q3 2021.

Based on Federated Hermes's 13F filing for Q3 2021, filed 15 Nov 2021.